Form 8-K - Current report:
SEC Accession No. 0001493152-25-013290
Filing Date
2025-09-12
Accepted
2025-09-12 17:29:25
Documents
14
Period of Report
2025-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 50694
2 EX-4.1 ex4-1.htm EX-4.1 35197
3 EX-10.1 ex10-1.htm EX-10.1 93389
  Complete submission text file 0001493152-25-013290.txt   373638

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gctk-20250912.xsd EX-101.SCH 3020
5 XBRL LABEL FILE gctk-20250912_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE gctk-20250912_pre.xml EX-101.PRE 22362
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3658
Mailing Address 301 RT 17 NORTH SUITE 800 RUTHERFORD NJ 07070
Business Address 301 RT 17 NORTH SUITE 800 RUTHERFORD NJ 07070 972 (8) 675-7878
Glucotrack, Inc. (Filer) CIK: 0001506983 (see all company filings)

EIN.: 980668934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41141 | Film No.: 251312512
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)